XML 59 R44.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 26, 2020
USD ($)
Dec. 28, 2019
USD ($)
Dec. 26, 2020
USD ($)
segment
Dec. 28, 2019
USD ($)
Segment Reporting [Abstract]        
Number of business units | segment     3  
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact $ 234,905 $ 257,064 $ 632,960 $ 742,720
Effect of exchange rates 494 (3,291) (2,922) (8,072)
Net revenues 240,371 258,970 645,434 749,987
Operating (loss) income 40,425 40,907 110,922 77,344
Effect of exchange rates 4,286 2,521 8,644 7,791
Amortization 7,805 5,772 24,204 17,681
Restructuring and turnaround costs (3,143) (7,798) (11,583) (13,582)
Transaction costs 0 0 (3,063) 0
PCS2 accelerated depreciation and related costs (1,146) (6,649) (3,332) (18,708)
European Medical Device Regulation costs and other (1,207) (448) (2,696) (304)
Impairment of assets and related costs 0 0 (896) (51,220)
Gain on sale of assets 1,115 0 32,613 8,083
United States        
Segment Reporting Information [Line Items]        
Net revenues 147,607 167,238 382,600 485,493
Japan        
Segment Reporting Information [Line Items]        
Net revenues 20,854 19,268 57,330 55,111
Europe        
Segment Reporting Information [Line Items]        
Net revenues 41,874 40,984 123,541 115,811
Asia        
Segment Reporting Information [Line Items]        
Net revenues 29,050 29,436 77,602 88,269
Other        
Segment Reporting Information [Line Items]        
Net revenues 986 2,044 4,361 5,303
Service        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 4,972 5,197 15,396 15,339
Plasma products and services        
Segment Reporting Information [Line Items]        
Net revenues 123,510 141,231 309,933 406,825
Blood Center products and services        
Segment Reporting Information [Line Items]        
Net revenues 62,787 66,126 182,687 191,648
Hospital products and services        
Segment Reporting Information [Line Items]        
Net revenues 54,074 51,613 152,814 151,514
Plasma        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 102,154 120,997 249,587 348,141
Blood Center        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 80,417 85,314 234,446 246,977
Hospital        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 52,334 50,753 148,927 147,602
Operating Segments        
Segment Reporting Information [Line Items]        
Operating (loss) income 111,527 122,133 300,444 351,328
Operating Segments | Plasma        
Segment Reporting Information [Line Items]        
Operating (loss) income 52,673 59,343 129,846 169,844
Operating Segments | Blood Center        
Segment Reporting Information [Line Items]        
Operating (loss) income 36,424 42,197 108,926 121,124
Operating Segments | Hospital        
Segment Reporting Information [Line Items]        
Operating (loss) income 22,430 20,593 61,672 60,360
Corporate        
Segment Reporting Information [Line Items]        
Corporate expenses $ (63,202) $ (63,080) $ (185,005) $ (188,363)